Ulcerative colitis
Conditions
Interventions
Targeted biopsy
Step biopsy
Sponsors
Teikyo University School of Medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1)Patients who has a histologically confirmed diagnosis of ulcerative colitis (Duration of disease 7 years or more, total colitis or left-sided colitis) 2)Simple clinical colitis activity index <= 8 3)Activity Index of Truelove and Witts: mild 4)Patients who can understand the concept of the study and consented to participate in the study
Exclusion criteria
Exclusion criteria: 1)Patients who have past history of colon cancer and/or ulcerative colitis associated neoplasm 2) Patients suspected of bleeding diathesis or coagulation abnormality 3) Renal dysfunction (Cre > 1.2 mg/dl) 4)Pregnancy or breast feeding 5)Otherwise, patiesnts who investigator judged ineligible to register
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The number of neoplastic lesions detected during surveillance colonoscopy | — |
Secondary
| Measure | Time frame |
|---|---|
| The detection rate of neoplastic lesions, examination time and a number of biopsies in the surveillance colonoscopy (economical efficiency, incidence rate of complication that requires the special treatment, risk factor of neoplasia) | — |
Countries
Japan
Contacts
Public ContactNaoki Tomotsugu
Keio University School of Medicine Center for Clinical Research
Outcome results
None listed